Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide( P-ICE) in patients with relapsed or refractory germ cell tumors (GCT).

T. Kegel,Franziska Cygon,Fabian Maximilian Meinert,Khaled Hammad,Frank Steinbach,Florian Seseke,Hans-Joachim Schmoll

Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide( P-ICE) in patients with relapsed or refractory germ cell tumors (GCT).

2017

T. Kegel
Franziska Cygon
Fabian Maximilian Meinert
Khaled Hammad
Frank Steinbach
Florian Seseke
Hans-Joachim Schmoll

4552Background: High-dose chemotherapy (HD-CTx) is an active option for salvage chemotherapy in patients (pts) with refractory or relapsed GCT. All previous trials with HD-CTx used one or two cycle...

Keywords:

Refractory
Germ cell tumors
Ifosfamide
Phases of clinical research
Carboplatin/etoposide
Paclitaxel
Pathology
Medicine
Cancer research
Chemotherapy
Oncology
in patient
high dose chemotherapy
Internal medicine
ifosfamide carboplatin etoposide

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations